# RIDAURA

NDC: 54766-093
Generic name: auranofin
Labeler / Manufacturer: Sebela Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20161215
Marketing ended: 20271031
FDA application: NDA018689

## Active ingredients

- AURANOFIN: 3 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"54766-093"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=54766-093
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43ba3de1-ab2e-06f6-e054-00144ff8d46c